Skip to main content
Top
Published in: Clinical and Experimental Nephrology 1/2015

01-02-2015 | Original Article

Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis

Authors: Tadaatsu Imaizumi, Tomomi Aizawa, Ryo Hayakari, Fei Xing, Pengfei Meng, Kazushi Tsuruga, Tomoh Matsumiya, Hidemi Yoshida, Liang Wang, Tetsuya Tatsuta, Hiroshi Tanaka

Published in: Clinical and Experimental Nephrology | Issue 1/2015

Login to get access

Abstract

Aim

It has been reported that tumor necrosis factor (TNF)-α plays dual controversial roles, beneficial or detrimental, in the pathogenesis of murine lupus nephritis (LN). However, its precise role in the development of human LN remains to be determined.

Methods

We examine the effect of pretreatment with TNF-α on the toll-like receptor 3 (TLR3) signaling induced by polyinosinic-polycytidylic acid (poly IC), a synthetic analog of viral dsRNA that makes “pseudoviral” infection in cultured normal human mesangial cells, and analyzed the expression of CC chemokine ligand 5 (CCL5) via TLR3/interferon (IFN)-β/retinoic acid-inducible gene-I (RIG-I) pathway by reverse transcriptase-polymerase chain reaction, Western blotting and enzyme-linked immunosorbent assay.

Results

We found synergistic effect of TNF-α, even at low level, on the expression of CCL5 induced by poly IC in a concentration-dependent manner, in comparison with that by poly IC alone. Knockdown of either IFN-β or RIG-I decreased CCL5 expression induced by TNF-α followed by poly IC.

Conclusion

Pretreatment with TNF-α leads marked activation of the TLR3/IFN-β/RIG-I/CCL5 axis induced by “pseudoviral” infection. Since chronic local activation of proinflammatory cytokines including TNF-α in resident renal cells may exist in patients with active lupus, synergistic effect of TNF-α and “pseudoviral” infection is possibly involved in the development of LN.
Literature
1.
go back to reference Koenig KF, Groeschl I, Pesickova SS, Tesar V, Eisenberger U, Trendelenburg M. Serum cytokine profile in patients with active lupus nephritis. Cytokine. 2012;60:410–6.CrossRefPubMed Koenig KF, Groeschl I, Pesickova SS, Tesar V, Eisenberger U, Trendelenburg M. Serum cytokine profile in patients with active lupus nephritis. Cytokine. 2012;60:410–6.CrossRefPubMed
2.
go back to reference Yap DYH, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrology (Carlton). 2013;18:243–55.CrossRef Yap DYH, Lai KN. The role of cytokines in the pathogenesis of systemic lupus erythematosus—from bench to bedside. Nephrology (Carlton). 2013;18:243–55.CrossRef
3.
go back to reference Yung S, Cheung KF, Zhang Q, Chan TM. Mediators of inflammation and their effect on resident renal cells: Implications in lupus nephritis. Clin Dev Immunol. 2013;2013:317682.CrossRefPubMedCentralPubMed Yung S, Cheung KF, Zhang Q, Chan TM. Mediators of inflammation and their effect on resident renal cells: Implications in lupus nephritis. Clin Dev Immunol. 2013;2013:317682.CrossRefPubMedCentralPubMed
4.
go back to reference Aringer M, Houssiau F, Gordon C, et al. Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology (Oxford). 2009;48:1451–4.CrossRef Aringer M, Houssiau F, Gordon C, et al. Adverse events and efficacy of TNF-α blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients. Rheumatology (Oxford). 2009;48:1451–4.CrossRef
6.
7.
go back to reference Migliorini A, Ebid R, Scherbaum CR, Anders HJ. The danger control concept in kidney disease: mesangial cells. J Nephrol. 2013;26:437–49.CrossRefPubMed Migliorini A, Ebid R, Scherbaum CR, Anders HJ. The danger control concept in kidney disease: mesangial cells. J Nephrol. 2013;26:437–49.CrossRefPubMed
8.
go back to reference Imaizumi T, Tanaka H, Matsumiya T, et al. Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells. Nephrol Dial Transpl. 2010;25:3534–9.CrossRef Imaizumi T, Tanaka H, Matsumiya T, et al. Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells. Nephrol Dial Transpl. 2010;25:3534–9.CrossRef
9.
go back to reference Imaizumi T, Aizawa-Yashiro T, Tsuruga K, et al. Melanoma differentiation- associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases. Tohoku J Exp Med. 2012;228:17–26.CrossRefPubMed Imaizumi T, Aizawa-Yashiro T, Tsuruga K, et al. Melanoma differentiation- associated gene 5 regulates the expression of a chemokine CXCL10 in human mesangial cells: implications for chronic inflammatory renal diseases. Tohoku J Exp Med. 2012;228:17–26.CrossRefPubMed
10.
go back to reference Aizawa-Yashiro T, Imaizumi T, Tsuruga K, et al. Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection. Pediatr Res. 2013;73:180–6.CrossRefPubMed Aizawa-Yashiro T, Imaizumi T, Tsuruga K, et al. Glomerular expression of fractalkine is induced by polyinosinic-polycytidylic acid in human mesangial cells: possible involvement of fractalkine after viral infection. Pediatr Res. 2013;73:180–6.CrossRefPubMed
11.
go back to reference Tanaka H, Imaizumi T. Inflammatory chemokine expression via Toll-like receptor 3 signaling in normal human mesangial cells. Clin Dev Immunol. 2013;2013:984708.PubMedCentralPubMed Tanaka H, Imaizumi T. Inflammatory chemokine expression via Toll-like receptor 3 signaling in normal human mesangial cells. Clin Dev Immunol. 2013;2013:984708.PubMedCentralPubMed
12.
go back to reference Watanabe S, Imaizumi T, Tsuruga K, et al. Glomerular expression of myxovirus resistance protein 1 (Mx1) in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology (Carlton). 2013;18:833–7.CrossRef Watanabe S, Imaizumi T, Tsuruga K, et al. Glomerular expression of myxovirus resistance protein 1 (Mx1) in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology (Carlton). 2013;18:833–7.CrossRef
13.
go back to reference Suzuki K, Imaizumi T, Oki E, Tsugawa K, Ito E, Tanaka H. Expression of retinoic acid-inducible gene-I in lupus nephritis. Nephrol Dial Transpl. 2007;22:2407–9.CrossRef Suzuki K, Imaizumi T, Oki E, Tsugawa K, Ito E, Tanaka H. Expression of retinoic acid-inducible gene-I in lupus nephritis. Nephrol Dial Transpl. 2007;22:2407–9.CrossRef
14.
go back to reference Chan RW, Lai FM, Li EK, et al. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis. Nephrology (Carlton). 2006;11:219–25.CrossRef Chan RW, Lai FM, Li EK, et al. Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis. Nephrology (Carlton). 2006;11:219–25.CrossRef
15.
go back to reference Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas (lpr) mice. Nephrol Dial Transpl. 2006;21:3062–73.CrossRef Patole PS, Pawar RD, Lech M, et al. Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas (lpr) mice. Nephrol Dial Transpl. 2006;21:3062–73.CrossRef
16.
17.
go back to reference Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5 and LGP2 in antiviral innate immunity. J Immunol. 2005;175:2851–8.CrossRefPubMed Yoneyama M, Kikuchi M, Matsumoto K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5 and LGP2 in antiviral innate immunity. J Immunol. 2005;175:2851–8.CrossRefPubMed
18.
go back to reference Satriano JA, Bana B, Luckow B, Nelson P, Schlondorff DO. Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J Am Soc Nephrol. 1997;8:596–603.PubMed Satriano JA, Bana B, Luckow B, Nelson P, Schlondorff DO. Regulation of RANTES and ICAM-1 expression in murine mesangial cells. J Am Soc Nephrol. 1997;8:596–603.PubMed
20.
go back to reference Wolf G, Aberle S, Thaiss F, et al. TNF-α induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 1993;44:795–804.CrossRefPubMed Wolf G, Aberle S, Thaiss F, et al. TNF-α induces expression of the chemoattractant cytokine RANTES in cultured mouse mesangial cells. Kidney Int. 1993;44:795–804.CrossRefPubMed
21.
go back to reference Anders HJ, Lichtnekert J, Allam R. Interferon-α and -β in kidney inflammation. Kidney Int. 2010;77:848–54.CrossRefPubMed Anders HJ, Lichtnekert J, Allam R. Interferon-α and -β in kidney inflammation. Kidney Int. 2010;77:848–54.CrossRefPubMed
Metadata
Title
Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis
Authors
Tadaatsu Imaizumi
Tomomi Aizawa
Ryo Hayakari
Fei Xing
Pengfei Meng
Kazushi Tsuruga
Tomoh Matsumiya
Hidemi Yoshida
Liang Wang
Tetsuya Tatsuta
Hiroshi Tanaka
Publication date
01-02-2015
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 1/2015
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-0956-3

Other articles of this Issue 1/2015

Clinical and Experimental Nephrology 1/2015 Go to the issue